title: Annual update: drugs, diagnostics and devices.
abstract: As NPs continue to play an important role in health care as administers of prescriptions, the value of reviewing the latest Food and Drug Administration (FDA) approvals for new drugs and devices is immeasurable. In 2002, the FDA approved several new drugs and devices, as well as monitored previously approved drugs for adverse reactions and untoward events. This article provides a brief review of relevant primary care topics.
authors.forename: Candace
authors.initials: C
authors.lastname: Berardinelli
authors.forename: Deborah
authors.initials: D
authors.lastname: Kupecz
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000188:drug therapy; D017277:Drug Approval; D004358:Drug Therapy / Q000639:trends*; D004509:Education, Nursing, Continuing; D004864:Equipment and Supplies; D015658:HIV Infections / Q000175:diagnosis; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy; D009722:Nurse Practitioners; D009293:Opioid-Related Disorders / Q000188:drug therapy; D013245:Sterilization, Reproductive
chemical_list: D000893:Anti-Inflammatory Agents